Photo from archive.org
Nontuberculous mycobacteria (NTM) cause difficult-to-treat opportunistic infections, most frequently of the lungs. Patients with chronic obstructive pulmonary diseases, cystic fibrosis or bronchiectasis are prone to NTM pulmonary disease (PD) and… Click to show full abstract
Nontuberculous mycobacteria (NTM) cause difficult-to-treat opportunistic infections, most frequently of the lungs. Patients with chronic obstructive pulmonary diseases, cystic fibrosis or bronchiectasis are prone to NTM pulmonary disease (PD) and other opportunistic infections, including by Aspergillus fumigatus. Co-infections are difficult to identify as diagnostic criteria for NTM-PD and chronic pulmonary aspergillosis (CPA) overlap [1, 2]. The literature suggests that NTM and Aspergillus co-infections are associated with higher mortality [3]. Therefore, Aspergillus serology is part of NTM-PD diagnostic work up in our reference centre. 40% of patients diagnosed with nontuberculous mycobacterial lung disease also meet diagnostic criteria for chronic pulmonary aspergillosis and Mycobacterium avium stimulates Aspergillus growth in vitro http://bit.ly/2JmLKk5
Journal Title: European Respiratory Journal
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!